Call 800 665 0411 to learn about our services

Search   Follow Investorideas on Twitter   Investorideas is on Facebook   Investorideas is on Youtube   Investorideas is on Pinterest  Investorideas is on stocktwits   Investorideas is on tumblr   Investorideas is on LinkedIn   Investorideas Instagram   Investorideas Telegram   Investorideas Gettr   Investorideas RSS

Share on StockTwits

Medical #Marijuana Protections Included in Senate CJS Appropriations Bill

The provision, which was included in the base bill for the first time ever, would continue to block the Justice Department from interfering in state medical marijuana laws


WASHINGTON - June 13, 2018 ( Newswire) For the first time ever, senators have included protections for state medical marijuana laws in their base Commerce, Justice, Science (CJS) Appropriations bill.

The Senate Appropriations Subcommittee on Commerce, Justice, Science and Related Agencies approved the spending legislation Tuesday, including a provision that would block the Justice Department from using funds to interfere in state medical marijuana laws. The overall bill is expected to receive a full committee vote Thursday.

Such a provision has been in effect since 2014, but this is the first time it has been included in the Senate's base CJS Appropriations bill. The House added a similar provision to its base CJS Appropriations bill in committee last month. The House version of the measure, known as the Rohrabacher-Farr amendment (and subsequently the Rohrabacher-Blumenauer amendment) was added to the bill as a floor amendment in previous years. Sen. Patrick Leahy (D-VT) was the most recent sponsor of the amendment in the Senate.

Statement from Don Murphy, director of conservative outreach for the Marijuana Policy Project:

"The inclusion of this provision in the base bill symbolizes just how far this issue has come. We have reached the point where even in a Republican-controlled Senate, a medical marijuana provision is not considered a poison pill and its support requires no further debate. Protecting state medical marijuana laws against federal interference is now viewed as commonsense rather than controversial.

"We did not reach this milestone easily. For years, patients, their families, and advocates have been fighting for compassionate medical marijuana laws at the state and federal levels. We now have at least some form of medical marijuana law in nearly every state in the nation, and polls show nearly universal support for allowing the medical use of marijuana. We commend Senate leaders for taking a proactive approach and including this important provision in the base CJS spending bill."

The Marijuana Policy Project is the nation's largest marijuana policy organization. For more information, visit

Marijuana / Hemp Stocks

Marijuana / Hemp Stocks

At and

Like Marijuana / Hemp Stocks? View our Marijuana / Hemp Stocks Directory

Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing

Also check out our AI blog Global Cannabis Investing - features Investor Ideas Cannabis news

More Info: Newswire

This news is published on the Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: Learn more about publishing your news release and our other news services on the newswire

Global investors must adhere to regulations of each country. Please read privacy policy:

Follow Us on StockTwits